For over 50 years, industrial and tertiary sectors have been required to treat their water using chemical biocides. However, the effects of these products are recognised to be incomplete, both for pathogenic bacteria - 99.5% of which are present in biofilms - and for free-living amoeba, which serve as a bacterial reservoir. In the absence of alternatives, industrial stake-holders and those responsible for water treatment have had to make do. In addition, these chemical biocides are known to be dangerous for humans and the environment, which makes it necessary to equip persons handling these products with Personal Protective Equipment (PPE).
Today, Amoéba listed on the regulated market of Euronext Paris, is proposing an alternative to these industrial companies and water treatment agencies: the only biological biocide (BIOMEBA/Green Biocide).
BIOMEBA consists of the amoeba Willaertia magna C2c Maky, which is the natural predator of pathogenic bacteria and free-living amoeba. This breakthrough biocide, meets the new Biocide standard, eliminating bacteria present in the water and in the biofilm. For the first time since 50 years, a product is available to treat 100% of the bacterial threat.
In addition, Green biocide/BIOMEBA can help you to reduce your costs, in particular by causing less damage to installations, and by limiting your carbon footprint by considerably reducing the supply chain.
Today, Amoéba's biocide is adapted for use in cooling towers (TP11). Its application does not require any modifications to your installation. Validation tests in installations have proven its relevance and efficacy, as attested by our clients testimonies. We are currently seeking authorisation for this application for its commercialisation on three continents. If you would like more information, we will be delighted to answer your questions, please contact us.
Other applications are being under development. The next application tested will be for the treatment of domestic hot water. If you would like further information, please contact us.